Lab Sette

Sette

Evaluation of the expression of CCR5 and CX3CR1 receptors and correlation with the functionality of T cells in women infected with ZIKV during pregnancy.

Ricardo Monterrosa
June 6, 2024

Sette

SARS-CoV-2 induces robust germinal center CD4T follicular helper cell responses in rhesus macaques.

Ricardo Monterrosa
June 6, 2024

Sette, Weiskopf

Immune memory in mild COVID-19 patients and unexposed donors reveals persistent T cell responses after SARS-CoV-2 infection.

Ricardo Monterrosa
June 6, 2024

Peters, Sette

TCRMatch: predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors.

Ricardo Monterrosa
June 6, 2024

Sette

Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacteria tuberculosis in the human lung.

Ricardo Monterrosa
June 6, 2024

Sette

Backbone modifications of HLA-A2-restricted antigens induce diverse binding and T cell activation outcomes.

Ricardo Monterrosa
June 6, 2024

Sette

Classical CD4 T cells as the cornerstone of antimycobacterial immunity.

Ricardo Monterrosa
June 6, 2024

Sette

The longest persistence of viable SARS-CoV-2 with Recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient-a case study.

Ricardo Monterrosa
June 6, 2024

Sette

Balanced cellular and humoral immune responses targeting multiple antigens in adult receiving a quadrivalent inactivated influenza vaccine.

Ricardo Monterrosa
June 6, 2024

Peters, Sette

A system-view of Bordetella pertussis booster vaccination responses in adults primed with whole-cell versus acellular vaccine in infancy.

Ricardo Monterrosa
June 6, 2024

Sette

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ricardo Monterrosa
June 6, 2024

Sette

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.

Ricardo Monterrosa
June 6, 2024

Peters, Sette

In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.

Ricardo Monterrosa
June 6, 2024

Peters, Sette

An immunologically friendly classification of non-peptidic ligands.

Ricardo Monterrosa
June 6, 2024

Sette

IgG epitopes processed and presented by IgG. B cells induce suppression by human thymic-derived regulatory T cells.

Ricardo Monterrosa
June 6, 2024

Peters, Sette, Sharma, Vijayanand

Functional analysis of immune signature genes in Th1* memory cells links ISOC1 and pyrimidine metabolism to IFN-g and IL-17 production.

Ricardo Monterrosa
June 6, 2024

Sette

Development of nasal allergen challenge with cockroach in children with asthma.

Ricardo Monterrosa
June 6, 2024

Sette

Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals.

Ricardo Monterrosa
June 6, 2024

Sette

Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis co-infection.

Ricardo Monterrosa
June 6, 2024

Sette

Pre-existing T cell memory against Zika virus.

Ricardo Monterrosa
June 6, 2024

Crotty, Sette

Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers.

Ricardo Monterrosa
June 6, 2024

Sette

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Ricardo Monterrosa
June 6, 2024

Crotty, Peters, Sette

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals.

Ricardo Monterrosa
June 6, 2024

Sette

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.

Ricardo Monterrosa
June 6, 2024

Peters, Sette, Vijayanand

HLA-DR marks recently divided antigen-specific effector CD4 T cells in active tuberculosis patients.

Ricardo Monterrosa
June 6, 2024

Crotty, Peters, Sette

SARS-CoV-2 human T cell epitopes: adaptive immune response against COVID-19.

Ricardo Monterrosa
June 6, 2024

Sette

Evaluation of ELISA-based multiplex peptides for the detection of human serum antibodies induced by Zika virus infection across various countries.

Ricardo Monterrosa
June 6, 2024

Sette

Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.

Ricardo Monterrosa
June 6, 2024

Sette

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HlA restricted.

Ricardo Monterrosa
June 6, 2024

Sette

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.

Ricardo Monterrosa
June 6, 2024

Sette

Characterization of conserved and promiscuous human rhinovirus CD4 T cell epitopes.

Ricardo Monterrosa
June 6, 2024

Sette

Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer.

Ricardo Monterrosa
June 6, 2024

Sette

Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates.

Ricardo Monterrosa
June 6, 2024

Peters, Schoenberger, Sette

The cancer epitope database and analysis resource: a blueprint for the establishment of a new bioinformatics resource for use by the cancer immunology community.

Ricardo Monterrosa
June 6, 2024

Sette

Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level.

Ricardo Monterrosa
June 6, 2024

Sette

PopCover-2.0. Improved selection of peptide sets with optimal HLA and pathogen diversity coverage.

Ricardo Monterrosa
June 6, 2024

Sette

CD8 + T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis.

Ricardo Monterrosa
June 6, 2024

Crotty, Sette

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.

Ricardo Monterrosa
June 6, 2024

Sette

Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection.

Ricardo Monterrosa
June 6, 2024

Sette

Heterogeneity of magnitude, allergen immunodominance, and cytokine polarization of cockroach allergen-specific T cell responses in allergic sensitized children.

Ricardo Monterrosa
June 6, 2024

Benedict, Sette

Profiling human cytomegalovirus-specific T cell responses reveals novel immunogenic open reading frames

Ricardo Monterrosa
June 6, 2024

Sette

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in a subgroup of healthy adults in Chile.

Ricardo Monterrosa
June 6, 2024

Crotty, Saphire, Sette

SARS-CoV-2 infection generates tissue-localized immunological memory in humans.

Ricardo Monterrosa
June 6, 2024

Sette

Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.

Ricardo Monterrosa
June 6, 2024

Sette

Immune signatures underlying post-acute COVID-19 lung sequelae.

Ricardo Monterrosa
June 6, 2024

Sette

High frequencies of functional virus-specific CD4 + T cells in SARS-CoV-2 subjects with olfactory and taste disorders.

Ricardo Monterrosa
June 6, 2024

Sette

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.

Ricardo Monterrosa
June 6, 2024

Sette

Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine.

Ricardo Monterrosa
June 6, 2024

Sette

Identification and characterization of Rift Valley fever virus-specific T cells reveals a dependence on CD40/CD40L interactions for prevention of encephalitis.

Ricardo Monterrosa
June 6, 2024

Sette

Interferon-γ release assay for accurate detection of severe acute respiratory syndrome coronavirus 2 T-cell response.

Ricardo Monterrosa
June 6, 2024

Sette

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.

Ricardo Monterrosa
June 6, 2024

Sette

Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors.

Ricardo Monterrosa
June 6, 2024

Sette

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.

Ricardo Monterrosa
June 6, 2024

Sette

Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex.

Ricardo Monterrosa
June 6, 2024

Sette

Central and peripheral inflammation: connecting the immune responses of Parkinson’s disease

Ricardo Monterrosa
June 6, 2024

Sette

From Alpha to omicron: The response of T cells

Ricardo Monterrosa
June 6, 2024

Sette

Epitope-specific T cell Receptor data and tools in the immune epitope database

Ricardo Monterrosa
June 6, 2024

Sette

Detection of α-synuclein-specific T cells in Parkinson’s disease

Ricardo Monterrosa
June 6, 2024

Peters, Sette, Vijayanand

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis

Ricardo Monterrosa
June 6, 2024

Sette

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.

Ricardo Monterrosa
June 6, 2024

Sette

The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.

Ricardo Monterrosa
June 6, 2024

Peters, Sette, Vijayanand

CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature.

Ricardo Monterrosa
June 6, 2024

Sette

Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared to COVID-19

Ricardo Monterrosa
June 6, 2024

Sette

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates

Ricardo Monterrosa
June 6, 2024

Sette

Positive-strand RNA viruses – a Keystone Symposia report

Ricardo Monterrosa
June 6, 2024

Sette

A population of CD4+CD8+ double-positive T cells associated with risk of plasma leakage in Dengue viral infection

Ricardo Monterrosa
June 6, 2024

Sette

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Ricardo Monterrosa
June 6, 2024

Sette

T cells, a-synuclein and Parkinson disease

Ricardo Monterrosa
June 6, 2024

Sette

NIAID workshop on T cell technologies

Ricardo Monterrosa
June 6, 2024

Crotty, Sette

NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses

Ricardo Monterrosa
June 6, 2024

Sette

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Ricardo Monterrosa
June 6, 2024

Sette

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Ricardo Monterrosa
June 6, 2024

Sette

Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1

Ricardo Monterrosa
June 6, 2024

Crotty, Sette

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines

Ricardo Monterrosa
June 6, 2024

Sette

Minimal Information about MHC Multimers (MIAMM)

Ricardo Monterrosa
June 6, 2024

Sette

Involvement of Th1Th17 cell subpopulations in the immune responses of mothers who gave birth to children with Congenital Zika syndrome (CZS)

Ricardo Monterrosa
June 6, 2024

Sette

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2

Ricardo Monterrosa
June 6, 2024

Sette

Current understanding of the role of T cells in Chikungunya, Dengue and Zika infections

Ricardo Monterrosa
June 6, 2024

Sette

Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response

Ricardo Monterrosa
June 6, 2024

Sette

Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients

Ricardo Monterrosa
June 6, 2024

Sette

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

Ricardo Monterrosa
June 6, 2024

Crotty, Grifoni, Sette

Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study

Ricardo Monterrosa
June 6, 2024

Sette

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

Ricardo Monterrosa
June 6, 2024

Sette

Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues

Ricardo Monterrosa
June 6, 2024

Sette

Responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with Ocrelizumab

Ricardo Monterrosa
June 6, 2024

Sette

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

Ricardo Monterrosa
June 6, 2024

Sette

Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling

Ricardo Monterrosa
June 6, 2024

Sette

T cells in multisystem inflammatory syndrome in children (MIS-C) have a predominant CD4+ T helper response to SARS-CoV-2 peptides and numerous virus-specific CD4- CD8-double-negative T cells

Ricardo Monterrosa
June 6, 2024

Sette

Early and polyantigenic CD4 T cell responses correlate with mild disease in acute COVID-19 donors

Ricardo Monterrosa
June 6, 2024

Sette

Predicting the success of fmoc-based peptide synthesis

Ricardo Monterrosa
June 6, 2024

Sette

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

Ricardo Monterrosa
June 6, 2024

Sette

An efficient immunoassay for the B-cell help function of SARS-CoV-2 specific memory CD4+ T cells

Ricardo Monterrosa
June 6, 2024

Sette

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial

Ricardo Monterrosa
June 6, 2024

Sette

CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infection

Ricardo Monterrosa
June 6, 2024

Sette

Humoral and cellular response to spike of Delta SARS-CoV-2 variant in vaccinated patients with multiple sclerosis

Ricardo Monterrosa
June 6, 2024

Sette

Mapping the MHC class I spliced immunopeptidome of cancer cells

Ricardo Monterrosa
June 6, 2024

Sette

Defining the risk of SARS-CoV-2 variants on immune protection

Ricardo Monterrosa
June 6, 2024

Crotty, Sette

Mpox vaccine and infection-driven human immune signatures

Ricardo Monterrosa
June 6, 2024

Sette

Immunodominant MHC-II restricted epitopes in human apolipoprotein B

Ricardo Monterrosa
June 6, 2024

Sette

Preserved SARS-CoV-2 vaccine cell-mediated immunogenicity in inflammatory bowel disease patients on immune-modulating therapies

Ricardo Monterrosa
June 6, 2024

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2024 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688